Alcami /AAI Pharma

Discussion in 'Alcami' started by anonymous, Jun 17, 2016 at 3:29 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Is the new leadership team making it any better or worse? Can't be as bad as everyone says
     

  2. anonymous

    anonymous Guest

    It is much worse.

    The formulations group has gone way down. When James Swarbrick was leading that group they actually did some interesting work, but that was many years ago. The current team is just doing basic stuff, nothing creative or anything close to cutting edge. There is almost no biopharmaceutical work being done, it is all solid dosage formulation. People join the group to get a little experience and then leave.
     
  3. anonymous

    anonymous Guest

    Even in the "good" days the formulations group was crap. The old Expo building was so bad that we would put trash cans on our desks to catch the leaks when it rained. I came into work one morning after a hard rain and the ceiling had collapsed, there was a dead possum in the trash can full of water. A real high class operation. The solids manufacturing was just as bad, old equipment, crappy quality and it has not improved with time. The Hall street labs were even worse.
     
  4. anonymous

    anonymous Guest


    Are the current formulation scientists talented and experienced? Are they from big pharma ?
     
  5. anonymous

    anonymous Guest

    They're saying tons of cash is being investited in new facilities, equipment and people
     
  6. anonymous

    anonymous Guest

    No. Talented and experienced people work elsewhere once they find out how bad things are. Why would someone with talent and experience waste time working on copycat drugs? AAI is for fresh grads to get experience or people in between companies to earn a paycheck.
     
  7. wilmington_1

    wilmington_1 new user

    Joined:
    Jan 3, 2017
    Messages:
    2
    Likes Received:
    0
    Your comp is off - but hey, it's the internet, feel free to be wrong!
     
  8. wilmington_1

    wilmington_1 new user

    Joined:
    Jan 3, 2017
    Messages:
    2
    Likes Received:
    0
    Mixture of Pharma, CDMO, and a 1 or 2 greenies.
     
  9. anonymous

    anonymous Guest

    are the hired any good?
     
  10. anonymous

    anonymous Guest

    Yeah it is low by a couple of bucks, but is not off by much. Entry level people get paid entry level wages. Alcami is not one of the top CROs/CMOs; the pay is commensurate. Most of what they do is pretty basic. It is a good place to get some experience and then people move on to bigger and better things. The only ones that stay are people who are tied to the area or have no other options.
     
  11. anonymous

    anonymous Guest

    The holding company that owns Alcami, American Capital, has been acquired by ARES. They said:

    "While significant progress was made with the American Capital portfolio after the merger agreement was signed, we expect a continued repositioning of its legacy investments to enhance earnings at the combined company and further improve our company’s outlook.”

    A lot of senior people have left from formulations, contracts, the biopharmaceuticals group is only a couple of people, turnover in analytical is really high. "Repositioning of legacy investments" , that is a nice way to say selling off the turds that don't make money. I wonder how long before the bloodletting begins?
     
  12. anonymous

    anonymous Guest

    We don't worry about staff turnover or the sale of Alcami to new owners.

    "There's a sucker born every minute."

    Let the churn begin! Bohica!
     
  13. anonymous

    anonymous Guest


    We hired Alcami to do our synthesis, they never did get it right. We then went with a company out of China who got it right the first time and for less. So much for American know how and quality.
     
  14. anonymous

    anonymous Guest

    Do not go to Alcami for a solid dose job. Old equipment, inadequate facilities and zero buy in from management. Basically a set-up to fail.
     
  15. anonymous

    anonymous Guest

    Do not go to Alcami for ANY job. The experienced people are leaving or have left already, amature hour is what you will get. Poor quality and excuses are the norm.
     
  16. anonymous

    anonymous Guest

    the amount of talented people that have left in the last year is shocking!
     
  17. anonymous

    anonymous Guest

    The number that have left is just the tip of the iceberg.

    Management is eager to push the old timers out as a cost saving measure, this is a shortsighted attempt to salvage a dying business. Either they simply do not understand that when you lose the experienced people you have damaged the business both in quality and capability, or they have no other options. Thanks to Pat Walsh AAI gambled on becoming a small molecule CMO with analytical capabilities, that has failed. The potential growth areas of Biotechnology and Cell Biology were abandoned in favor of a commodity business. Fred's vision of being a first in class CRO faded long ago. The current crop of fools mismanaging the company will leave with bonuses and will continue to lie about how well they have done.
     
  18. anonymous

    anonymous Guest

    Who is Fred?
     
  19. anonymous

    anonymous Guest

     
  20. anonymous

    anonymous Guest

    Matthew does not like all of the diversity here. Finds it to be quite useless and troublesome.